Drug Information Association (DIA) names new worldwide executive director

11-Sep-2009 - USA

The Drug Information Association (DIA) announced the hiring of Paul Pomerantz, MBA, CAE, as its new worldwide executive director. Paul will transition from his current position as executive vice president of the American Society of Plastic Surgeons (ASPS) to DIA worldwide executive director effective December 1, 2009. Pomerantz replaces William Brassington, MBA, who has served as acting executive director since July 2008. Brassington will resume his role as worldwide director of finance at DIA.

Pomerantz will direct DIA’s global operations and strategic expansion and lead the implementation of the Board of Director’s long-term plan for sustainability and growth. He is eager to work with DIA’s board, management team, and staff to take DIA to the next level of excellence.

Pomerantz brings to DIA more than 25 years of healthcare experience with specialized expertise in medical society management and hospital administration.

As executive vice president at ASPS, an association of 7,000 reconstructive and cosmetic plastic surgeons, Pomerantz was responsible for the association’s health policy and advocacy initiatives, education and research programs, membership services, communications, and the finance, administration, human resources, and information technology departments. In addition, he recently served (2008-09) as chair of the board of ASAE’s Center for Association Leadership. From 1997-2002 Pomerantz was executive director for the Society of Interventional Radiology (SIR), an international society representing specialty of radiology that uses image guidance to perform minimally invasive surgical procedures. Prior to SIR, Pomerantz served as executive director for the Clinical Laboratory Management Association, assistant vice president for the Medical College of Pennsylvania, executive director for Maxicare Philadelphia, and deputy director for the U.S. Public Health Service.

Other news from the department people

Most read news

More news from our other portals

Fighting cancer: latest developments and advances